New Orleans, LA – According to filings with the U.S. Securities and Exchange Commission, AxoSim is raising $3,765,996.00 in new funding. Sources indicate as part of senior management President, Lowry Curley played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About AxoSim

AxoSim empowers advancements in human neuroscience and accelerates the drug development process through our drug discovery platforms, NerveSim and BrainSim. We deliver human data, faster. This reduces clinical failure and enables companies to develop effective drugs more quickly and at lower cost. We work with our clients to become an integral part of the drug development process, fostering innovation and facilitating breakthroughs in the treatment of the world’s most devastating diseases.

To learn more about AxoSim, visit http://www.axosim.com/

Contact:
Lowry Curley, President
504-407-7419
lowry.curley@axosim.com
https://www.linkedin.com/in/lowrycurley/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved